1. The brain tissue response to surgical injury and its possible contribution to glioma recurrence

   • Lauriane Hamard
   • David Ratel
   • Didier Wion

   Topic Review 09 March 2016 Pages: 1 - 8

   

2. Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells

   • Angelo Torres
   • Yosselyn Vargas
   • Claudia Quezada

   Laboratory Investigation 22 February 2016 Pages: 9 - 19

   

3. Cationizable lipid micelles as vehicles for intraarterial glioma treatment

   • Juliane Nguyen
   • Johann R. N. Cooke
   • Shailendra Joshi

   Laboratory Investigation 22 February 2016 Pages: 21 - 28

   

4. Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1

   • Jungwhoi Lee
   • Eunsoo Kim
   • Kyungsun Choi

   Laboratory Investigation 07 March 2016 Pages: 29 - 34

   

5. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway

   • Li Hong
   • Liu Ya-wei
   • Lu Yun-tao

   Laboratory Investigation 12 March 2016 Pages: 35 - 45

   

6. Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma

   • Holly Lindsay
   • Yulun Huang
   • Xiao-Nan Li

   Laboratory Investigation 08 March 2016 Pages: 47 - 56

   

7. Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids

   • Eduard H. Panosyan
   • Joseph L. Lasky
   • P. Leia Nghiemphu

   Clinical Study 27 February 2016 Pages: 57 - 66

   

8. Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma

   • Cecelia Elizabeth Gzell
   • Helen R. Wheeler
   • Michael Back

   Clinical Study 15 February 2016 Pages: 67 - 74

   

9. Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study

   • Carlos Kamiya-Matsuoka
   • Asif M. Paker
   • Monica E. Loghin

   Clinical Study 22 February 2016 Pages: 75 - 84

   

10. Recurrent glioblastoma: who receives tumor specific treatment and how often?

    • Rieke Steffens
    • Sabine Semrau
    • Rainer Fietkau

    Clinical Study 23 February 2016 Pages: 85 - 92

    

11. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases

    • Yingmei Li
    • Wenying Pan
    • Melanie Hayden Gephart

    Clinical Study 09 March 2016 Pages: 93 - 100

    

12. Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?

    • Matthew L. Carlson
    • Neil S. Patel
    • Michael J. Link

    Clinical Study 22 February 2016 Pages: 101 - 108

    

13. Neuro-oncology family caregivers are at risk for systemic inflammation

    • Paula R. Sherwood
    • Thomas J. Price
    • Anna L. Marsland

    Clinical Study 23 February 2016 Pages: 109 - 118

    

14. Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries

    • Deborah C. Marshall
    • Logan P. Marcus
    • Clark C. Chen

    Clinical Study 07 March 2016 Pages: 119 - 128

    

15. Clinical features of subarachnoid hemorrhage in patients with positive cancer history

    • Ichiyo Shibahara
    • Takashi Watanabe
    • Teiji Tominaga

    Clinical Study 20 February 2016 Pages: 129 - 136

    

16. Pencil beam scanning proton therapy for pediatric intracranial ependymoma

    • Carmen Ares
    • Francesca Albertini
    • Damien C. Weber

    Clinical Study 05 March 2016 Pages: 137 - 145

    

17. Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

    • J. Duerinck
    • S. Du Four
    • B. Neyns

    Clinical Study 02 March 2016 Pages: 147 - 155

    

18. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

    • Enrico Franceschi
    • Roberta Depenni
    • The PERNO Study Group

    Clinical Study 04 March 2016 Pages: 157 - 162

    

19. Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

    • Mustafa Khasraw
    • Adrian Lee
    • Helen Wheeler

    Clinical Study 02 March 2016 Pages: 163 - 171

    

20. Comment on: the role of biopsy in the management of patients with presumed diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline

    • Christoph Schwartz
    • Friedrich-Wilhelm Kreth

    Letter to the Editor 26 February 2016 Pages: 173 - 173

21. Neuro-oncology biotech industry progress report

    • Shamik Chakraborty
    • Imithri Bodhinayake
    • John A. Boockvar

    Meeting Proceedings 20 February 2016 Pages: 175 - 182

22. Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

    • Dimitrios Mathios
    • Jacob Ruzevick
    • Michael Lim

    Erratum 09 May 2016 Pages: 183 - 183